Gilead Sciences Inc buy stefan
Start price
29.04.20
/
50%
€77.15
Target price
20.09.20
-
Performance (%)
-28.79%
End price
20.09.20
€54.94
Summary
This prediction ended on 20.09.20 with a price of €54.94. The price of Gilead Sciences Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.79%. A total of €1.17 was paid as dividends for this prediction. stefan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gilead Sciences Inc | -1.539% | -1.539% | 15.398% | 23.488% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by stefan for this prediction
In the thread Gilead Sciences Inc diskutieren
Gibt wohl doch positive Nachrichten zum Corona Medikament
https://www.cnbc.com/2020/04/28/stock-market-futures-open-to-close-news.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/29/gilead-reports-positive-data-on-remdesivir-coronavirus-drug-trial.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/28/stock-market-futures-open-to-close-news.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/29/gilead-reports-positive-data-on-remdesivir-coronavirus-drug-trial.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
In the thread Trading Gilead Sciences Inc
Buy beendet


